Ruffer LLP Harmony Biosciences Holdings, Inc. Transaction History
Ruffer LLP
- $2.68 Billion
- Q4 2024
A detailed history of Ruffer LLP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ruffer LLP holds 75,501 shares of HRMY stock, worth $2.59 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
75,501Holding current value
$2.59 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$227 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$162 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$78.2 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.03B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...